That was a big nothing earnings call. It’s time for a new CEO from outside the company to either sell or make strategic acquisitions. Oncology is stacked with Sleep and EMD needing more life. It is time to merge Sleep and EMD into one neuro franchise, there is nothing meaningful in our pipeline to justify keeping these groups separated.
